CEO Brian Blaser explained seasonal revenue trends for QuidelOrtho on August 13, 2025.
2 reports, 2 independent
Updated Aug 13
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CEO Brian Blaser explained seasonal revenue trends for QuidelOrtho on August 13, 2025.
Coverage
Newest first; wire copies grouped- StockStoryQDEL Q2 Deep Dive: Cost Controls and International Growth Offset Lower COVID Diagnostics Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) met Wall Street’s revenue expectations in Q2 CY2025,
- PR NewswireQuidelOrtho Reports Second Quarter 2025 Financial Results ― Labs revenue grew 4% as reported and 5% in constant currency ― ― Adjusted EBITDA margin improved by 330 basis points; Achieved $100 million